국제약품 분기보고서 (2019.03)
1. 요약재무정보

가. 요약연결재무정보

국제약품(주) 및 종속기업 (단위 : 원)

구 분	제62기 1분기	제61기	제60기

[유동자산]	62,475,440,997	54,559,369,036	59,537,268,607

-현금및현금성자산	1,387,346,060	3,658,579,316	2,526,446,742

-매출채권	23,446,480,696	24,356,918,543	34,631,990,387

-재고자산	17,711,763,566	14,183,645,117	17,161,676,070

-기타유동자산	19,929,850,675	12,360,226,060	5,217,155,408

[비유동자산]	74,648,025,774	71,675,526,598	72,109,077,814

-유형자산	62,257,567,726	61,277,407,372	60,644,614,964

-무형자산	1,818,442,492	1,872,761,740	2,793,348,551

-투자부동산	4,202,562,036	4,238,926,338	4,384,383,546

-기타비유동자산	6,369,453,520	4,286,431,148	4,286,730,753

자산총계	137,123,466,771	126,234,895,634	131,646,346,421

[유동부채]	55,118,524,583	48,199,751,500	50,577,481,456

[비유동부채]	11,873,582,314	9,336,991,512	13,290,560,555

부채총계	66,992,106,897	57,536,743,012	63,868,042,011

[자본금]	18,057,107,000	18,057,107,000	17,396,596,000

[주식발행초과금]	3,871,568,192	3,871,568,192	3,871,568,192

[기타포괄손익누계액]	22,430,885,101	22,177,699,694	22,507,671,905

[기타자본항목]	17,038,805,877	16,695,392,877	16,712,796,711

[이익잉여금]	8,708,698,001	7,870,638,339	7,254,177,296

지배기업소유주지분	70,107,064,171	68,672,406,102	67,742,810,104

비지배지분	24,295,703	25,746,520	35,494,306

자본총계	70,131,359,874	68,698,152,622	67,778,304,410

부채와자본총계	137,123,466,771	126,234,895,634	131,646,346,421

매출액	26,854,442,961	107,681,163,418	123,310,224,120

영업이익	2,554,478,031	3,287,017,509	2,564,176,442

당기순이익	2,026,751,114	2,182,873,368	1,038,655,256

1.지배기업소유주지분	2,028,201,931	2,192,621,154	1,092,249,307

2.비지배지분	(1,450,817)	(9,747,786)	(53,594,051)

기타포괄손익	(7,825,282)	(558,114,444)	(321,021,064)

당기총포괄이익	2,018,925,832	1,624,758,924	717,634,192

1.지배기업소유주지분	2,020,376,649	1,634,506,710	771,288,243

2.비지배지분	(1,450,817)	(9,747,786)	(53,594,051)

주당순이익	118	128	64

연결에 포함된 회사수	1	1	1

요약>(2019년 1분기) (단위:천원)

회사명	총자산	자기자본	매출액	당기순손익

케이제이케어(주)	1,251,956	455,544	466,698	(27,203)

(2018년) (단위:천원)

회사명	총자산	자기자본	매출액	당기순손익

케이제이케어(주)	1,171,994	482,747	1,533,821	(182,771)

(2017년) (단위:천원)

회사명	총자산	자기자본	매출액	당기순손익

케이제이케어(주)	1,417,804	665,518	1,882,224	(627,664)

나. 요약재무정보국제약품(주) (단위 : 원)

구 분	제62기 1분기	제61기	제60기

[유동자산]	61,608,181,422	53,591,579,999	58,966,762,270

-현금및현금성자산	1,183,549,543	3,343,108,063	2,101,785,914

-매출채권	23,120,470,024	24,069,101,895	34,939,210,196

-재고자산	17,391,474,960	13,837,452,079	16,747,438,175

-기타유동자산	19,912,686,895	12,341,917,962	5,178,327,985

[비유동자산]	74,361,850,484	71,518,152,473	72,056,470,418

-유형자산	62,123,054,588	61,144,981,394	60,502,977,261

-무형자산	1,815,269,053	1,869,588,301	2,790,175,112

-투자부동산	4,202,562,036	4,238,926,338	4,384,383,546

-기타비유동자산	6,220,964,807	4,264,656,440	4,378,934,499

자산총계	135,970,031,906	125,109,732,472	131,023,232,688

[유동부채]	55,024,203,243	48,116,428,802	50,483,528,373

[비유동부채]	11,741,413,990	9,281,215,987	13,262,882,445

부채총계	66,765,617,233	57,397,644,789	63,746,410,818

[자본금]	18,057,107,000	18,057,107,000	17,396,596,000

[주식발행초과금]	3,871,568,192	3,871,568,192	3,871,568,192

[기타포괄손익누계액]	22,430,885,101	22,177,699,694	22,507,671,905

[기타자본항목]	17,212,149,804	16,868,736,804	16,886,140,638

[이익잉여금]	7,632,704,576	6,736,975,993	6,614,845,135

자본총계	69,204,414,673	67,712,087,683	67,276,821,870

자본과부채총계	135,970,031,906	125,109,732,472	131,023,232,688

종속·관계·공동기업
투자주식의 평가방법	원가법	원가법	원가법

매출액	26,392,059,902	106,305,202,738	122,290,580,841

영업이익	2,580,968,115	2,978,856,968	3,409,551,640

당기순이익	2,085,870,852	1,698,290,969	710,891,007

기타포괄손익	(7,825,282)	(558,114,444)	(321,021,064)

당기총포괄이익	2,078,045,570	1,140,176,525	389,869,943

주당순이익	121	99	41